BioCentury
ARTICLE | Company News

Il-Yang Pharmaceutical Company Ltd., Tap Pharmaceutical deal

September 12, 2005 7:00 AM UTC

Il-Yang granted Tap a license to develop and distribute ilaprazole worldwide, excluding South Korea and China. Il-Yang is eligible for $40-$50 million in milestones. The proton pump inhibitor is expec...